Rxsight Inc (RXST) stock news · rev $134.5M
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
This RXST news page leads with what Rxsight Inc filed — not a scraped headline mill.
No cached 8-K sentence for RXST yet. We will not pad this page with generic market recap.
Latest reported RXST revenue for 2025-12-31 was $134.5M. Net income was -$38.9M. Revenue was down 3.9% from 2024-12-31 to 2025-12-31. RXST currently screens at market cap $198.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RXST stock page; for the tape open the quote page.
RXST stock news FAQ
What are RXST's latest revenue and net income?
Latest cached Rxsight Inc (RXST) revenue for Dec 31, 2025 was $134.5M. Net income was -$38.9M. Statements: https://lician.com/financials/rxst
How did RXST revenue change from the prior cached period?
Cached Rxsight Inc (RXST) revenue was down 3.9% from $139.9M (Dec 31, 2024) to $134.5M (Dec 31, 2025). Statements: https://lician.com/financials/rxst
What is RXST's market cap?
Rxsight Inc (RXST) market cap is $198.3M on the latest cached fundamentals snapshot.
What kind of company is RXST?
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
Where is RXST stock news listed?
Cached stock news for Rxsight Inc (RXST) is listed at https://lician.com/news/rxst. Filings: https://lician.com/sec/rxst
Not investment advice.